BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23912262)

  • 21. Nogo-A inhibits vascular regeneration in ischemic retinopathy.
    Joly S; Dejda A; Rodriguez L; Sapieha P; Pernet V
    Glia; 2018 Oct; 66(10):2079-2093. PubMed ID: 30051920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap).
    Rojo Arias JE; Jászai J
    Sci Rep; 2021 Jul; 11(1):15313. PubMed ID: 34321516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
    DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
    Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.
    Zhao L; Ma W; Fariss RN; Wong WT
    Exp Eye Res; 2009 Jun; 88(6):1004-13. PubMed ID: 19176215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
    Cheng G; He T; Xing Y
    Eye (Lond); 2016 Jun; 30(6):877-87. PubMed ID: 26987588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model.
    Ma Y; Li T
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33871456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.
    Dailey WA; Drenser KA; Wong SC; Cheng M; Vercellone J; Roumayah KK; Feeney EV; Deshpande M; Guzman AE; Trese M; Mitton KP
    Exp Eye Res; 2017 Nov; 164():129-138. PubMed ID: 28823941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.
    Connor KM; Krah NM; Dennison RJ; Aderman CM; Chen J; Guerin KI; Sapieha P; Stahl A; Willett KL; Smith LE
    Nat Protoc; 2009; 4(11):1565-73. PubMed ID: 19816419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke.
    Zhu HR; Wang ZY; Zhu XL; Wu XX; Li EG; Xu Y
    Neuropharmacology; 2010; 59(1-2):70-6. PubMed ID: 20381504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
    Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
    Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
    Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
    Scott A; Powner MB; Fruttiger M
    Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal Delivery of VEGF-A
    Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
    Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
    Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
    FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
    Piao L; Zhao G; Zhu E; Inoue A; Shibata R; Lei Y; Hu L; Yu C; Yang G; Wu H; Xu W; Okumura K; Ouchi N; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina.
    Weidemann A; Krohne TU; Aguilar E; Kurihara T; Takeda N; Dorrell MI; Simon MC; Haase VH; Friedlander M; Johnson RS
    Glia; 2010 Aug; 58(10):1177-85. PubMed ID: 20544853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
    Pierce EA; Foley ED; Smith LE
    Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic.
    O'Leary OE; Canning P; Reid E; Bertelli PM; McKeown S; Brines M; Cerami A; Du X; Xu H; Chen M; Dutton L; Brazil DP; Medina RJ; Stitt AW
    Exp Eye Res; 2019 May; 182():144-155. PubMed ID: 30876881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
    Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.